Cargando…
Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital
BACKGROUND: Procalcitonin (PCT) is a useful marker for pneumonia. However, its clinical usefulness in elderly patients has not been studied extensively. This study aimed to assess the relationship between PCT and prognosis and pneumonia severity in elderly patients with pneumonia acquired outside th...
Autores principales: | Akagi, Takanori, Nagata, Nobuhiko, Miyazaki, Hiroyuki, Harada, Taishi, Takeda, Satoshi, Yoshida, Yuji, Wada, Kenji, Fujita, Masaki, Watanabe, Kentaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323702/ https://www.ncbi.nlm.nih.gov/pubmed/30616612 http://dx.doi.org/10.1186/s12877-018-1008-8 |
Ejemplares similares
-
Role of procalcitonin in diagnosis of community acquired pneumonia in Children
por: Ratageri, Vinod H., et al.
Publicado: (2022) -
The effect of vitamin C on procalcitonin biomarker in community‐acquired pneumonia
por: Nikzad, Mahsa, et al.
Publicado: (2021) -
ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022) -
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017) -
Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD
por: Çolak, Ayfer, et al.
Publicado: (2017)